{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:54:12Z","timestamp":1781610852018,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012320","name":"Otto-von-Guericke-Universit\u00e4t Magdeburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012320","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Advanced MR imaging methods, such as perfusion, spectroscopy and diffusion-weighted imaging (DWI), help to distinguish between different types of brain tumors. We have established a rapid wash-out and late-enhancement map in our clinic. The aim of our study was to evaluate the potential usefulness of this map for the initial diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We included patients with a histologically confirmed initial diagnosis of brain metastasis and glioblastoma who underwent our MR protocol, including MR perfusion and rapid wash-out imaging, between January 1, 2024, and March 31, 2025. The rapid wash-out and late enhancement maps are derived from two contrast-enhanced T1-weighted 3D datasets acquired at 5 and 25\u00a0min after contrast injection. We volumetrically measured the late-enhancement and wash-out of brain tumors at initial diagnosis, and analyzed the wash-out ratio as volume (wash-out) \u2236 volume (wash-out +\u2009late enhancement). Additionally, we evaluated the relative cerebral blood volume (rCBV) and the apparent diffusion coefficient (ADC) ratios.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Forty-three patients were included in the study: 21 with glioblastoma and 22 with brain metastases. For glioblastoma, the mean wash-out ratio was 0.39\u2009\u00b1\u20090.21, the ADC ratio 1.41\u2009\u00b1\u20090.33, and the rCBV ratio 3.49\u2009\u00b1\u20091.25. In comparison, brain metastases showed a mean wash-out ratio of 0.23\u2009\u00b1\u20090.15, an ADC ratio of 1.38\u2009\u00b1\u20090.47, and an rCBV ratio of 2.25\u2009\u00b1\u20091.55. While rCBV ratio and wash-out ratio exhibited significant differences between glioblastomas and brain metastases, no such differences were observed in ADC ratios. An area-under-curve analysis revealed a ratio of 0.29 as the best threshold (for tumors larger than 1\u00a0cm\u00b3) for the wash-out ratio to distinguish glioblastomas and brain metastases with a sensitivity of 70% and a specificity of 75%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The wash-out ratio serves as an additional valuable marker for distinguishing between glioblastoma and brain metastases. Since MR perfusion is not always reliable for this differentiation, this novel method provides additional diagnostic confidence during the initial assessment. Combining rCBV and wash-out ratios may provide higher diagnostic accuracy than using either method individually.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12880-025-01889-6","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T08:50:46Z","timestamp":1756284646000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Late enhancement and wash-out maps for differentiation of glioblastoma and metastases"],"prefix":"10.1186","volume":"25","author":[{"given":"Leon","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eya","family":"Khadhraoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Klebingat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. Erol","family":"Sandalcioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belal","family":"Neyazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Behme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus-Peter","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2147-9797","authenticated-orcid":false,"given":"Sebastian Johannes","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"key":"1889_CR1","doi-asserted-by":"publisher","unstructured":"Price M, Neff C, Nagarajan N, Kruchko C, Waite KA, Cioffi G et al. CBTRUS statistical report: American brain tumor association & NCI neuro-oncology branch adolescent and young adult primary brain and other central nervous system tumors diagnosed in the United States in 2016\u20132020. Neuro-Oncol. 2024;26 Supplement_3:iii1\u201353. https:\/\/doi.org\/10.1093\/neuonc\/noae047","DOI":"10.1093\/neuonc\/noae047"},{"key":"1889_CR2","doi-asserted-by":"publisher","unstructured":"Ayaaba Ayabilah E, Yaw Nyantakyi A, Daniels J. Overview of brain metastasis and treatment modalities. In: Birol Sarica F, editor. Central Nervous System Tumors - Primary and Secondary. IntechOpen. 2023. https:\/\/doi.org\/10.5772\/intechopen.106789","DOI":"10.5772\/intechopen.106789"},{"key":"1889_CR3","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3978\/j.issn.2224-5820.2015.09.01","volume":"4","author":"MN Tsao","year":"2015","unstructured":"Tsao MN. Brain metastases: advances over the decades. Ann Palliat Med. 2015;4:225\u201332. https:\/\/doi.org\/10.3978\/j.issn.2224-5820.2015.09.01.","journal-title":"Ann Palliat Med"},{"key":"1889_CR4","doi-asserted-by":"publisher","first-page":"107327482513220","DOI":"10.1177\/10732748251322072","volume":"32","author":"N Kertmen","year":"2025","unstructured":"Kertmen N, Kavgaci G, Akin S, Coban G, Isikay AI, Yazici G. Evaluating immunotherapy responses in Neuro-Oncology for glioblastoma and brain metastases: A brief review featuring three cases. Cancer Control. 2025;32:10732748251322072. https:\/\/doi.org\/10.1177\/10732748251322072.","journal-title":"Cancer Control"},{"key":"1889_CR5","doi-asserted-by":"publisher","first-page":"7207","DOI":"10.3390\/ijms23137207","volume":"23","author":"A Rodr\u00edguez-Camacho","year":"2022","unstructured":"Rodr\u00edguez-Camacho A, Flores-V\u00e1zquez JG, Moscardini-Martelli J, Torres-R\u00edos JA, Olmos-Guzm\u00e1n A, Ortiz-Arce CS, et al. Glioblastoma treatment: State-of-the-Art and future perspectives. Int J Mol Sci. 2022;23:7207. https:\/\/doi.org\/10.3390\/ijms23137207.","journal-title":"Int J Mol Sci"},{"key":"1889_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12880-023-01183-3","volume":"24","author":"SJ M\u00fcller","year":"2024","unstructured":"M\u00fcller SJ, Khadhraoui E, Ernst M, Rohde V, Schatlo B, Malinova V. Differentiation of multiple brain metastases and glioblastoma with multiple foci using MRI criteria. BMC Med Imaging. 2024;24:3. https:\/\/doi.org\/10.1186\/s12880-023-01183-3.","journal-title":"BMC Med Imaging"},{"key":"1889_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.29473","author":"S Mohammadi","year":"2024","unstructured":"Mohammadi S, Ghaderi S, Jouzdani AF, Azinkhah I, Alibabaei S, Azami M, et al. Differentiation between High-Grade glioma and brain metastasis using cerebral Perfusion\u2010Related parameters (Cerebral blood volume and cerebral blood Flow): A Systematic Review and Meta\u2010Analysis of Perfusion\u2010weighted MRI Techniques. J Magn Reson Imaging. 2024. https:\/\/doi.org\/10.1002\/jmri.29473.","journal-title":"J Magn Reson Imaging"},{"key":"1889_CR8","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.acra.2009.08.014","volume":"17","author":"T Engelhorn","year":"2010","unstructured":"Engelhorn T, Schwarz MA, Eyupoglu IY, Kloska SP, Struffert T, Doerfler A. Dynamic contrast enhancement of experimental glioma. Acad Radiol. 2010;17:188\u201393. https:\/\/doi.org\/10.1016\/j.acra.2009.08.014.","journal-title":"Acad Radiol"},{"key":"1889_CR9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/RLI.0b013e31819ba711","volume":"44","author":"UI Attenberger","year":"2009","unstructured":"Attenberger UI, Runge VM, Jackson CB, Baumann S, Birkemeier K, Michaely HJ, et al. Comparative evaluation of lesion enhancement using 1\u00a0M Gadobutrol vs. 2 conventional gadolinium chelates, all at a dose of 0.1 mmol\/kg, in a rat brain tumor model at 3 T. Invest Radiol. 2009;44:251\u20136. https:\/\/doi.org\/10.1097\/RLI.0b013e31819ba711.","journal-title":"Invest Radiol"},{"key":"1889_CR10","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1186\/s12885-024-12909-z","volume":"24","author":"E Khadhraoui","year":"2024","unstructured":"Khadhraoui E, Schmidt L, Klebingat S, Schwab R, Hern\u00e1ndez-Dur\u00e1n S, Gihr G, et al. Comparison of a new MR rapid wash-out map with MR perfusion in brain tumors. BMC Cancer. 2024;24:1139. https:\/\/doi.org\/10.1186\/s12885-024-12909-z.","journal-title":"BMC Cancer"},{"key":"1889_CR11","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.neuroimage.2011.09.015","volume":"62","author":"M Jenkinson","year":"2012","unstructured":"Jenkinson M, Beckmann CF, Behrens TEJ, Woolrich MW, Smith SM. FSL NeuroImage. 2012;62:782\u201390. https:\/\/doi.org\/10.1016\/j.neuroimage.2011.09.015.","journal-title":"FSL NeuroImage"},{"key":"1889_CR12","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1006\/nimg.2002.1132","volume":"17","author":"M Jenkinson","year":"2002","unstructured":"Jenkinson M, Bannister P, Brady M, Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. NeuroImage. 2002;17:825\u201341. https:\/\/doi.org\/10.1006\/nimg.2002.1132.","journal-title":"NeuroImage"},{"key":"1889_CR13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neuroimage.2009.06.060","volume":"48","author":"DN Greve","year":"2009","unstructured":"Greve DN, Fischl B. Accurate and robust brain image alignment using boundary-based registration. NeuroImage. 2009;48:63\u201372. https:\/\/doi.org\/10.1016\/j.neuroimage.2009.06.060.","journal-title":"NeuroImage"},{"key":"1889_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S1361-8415(01)00036-6","volume":"5","author":"M Jenkinson","year":"2001","unstructured":"Jenkinson M, Smith S. A global optimisation method for robust affine registration of brain images. Med Image Anal. 2001;5:143\u201356. https:\/\/doi.org\/10.1016\/S1361-8415(01)00036-6.","journal-title":"Med Image Anal"},{"key":"1889_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-024-04573-x","author":"SJ M\u00fcller","year":"2024","unstructured":"M\u00fcller SJ, Khadhraoui E, Ganslandt O, Henkes H, Gihr GA. MRI treatment response assessment maps (TRAMs) for differentiating recurrent glioblastoma from radiation necrosis. J Neurooncol. 2024. https:\/\/doi.org\/10.1007\/s11060-024-04573-x.","journal-title":"J Neurooncol"},{"key":"1889_CR16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12880-021-00602-7","volume":"21","author":"SJ M\u00fcller","year":"2021","unstructured":"M\u00fcller SJ, Khadhraoui E, Neef NE, Riedel CH, Ernst M. Differentiation of brain metastases from small and non-small lung cancers using apparent diffusion coefficient (ADC) maps. BMC Med Imaging. 2021;21:70. https:\/\/doi.org\/10.1186\/s12880-021-00602-7.","journal-title":"BMC Med Imaging"},{"key":"1889_CR17","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.crad.2004.09.009","volume":"60","author":"B Hakyemez","year":"2005","unstructured":"Hakyemez B, Erdogan C, Ercan I, Ergin N, Uysal S, Atahan S. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging. Clin Radiol. 2005;60:493\u2013502. https:\/\/doi.org\/10.1016\/j.crad.2004.09.009.","journal-title":"Clin Radiol"},{"key":"1889_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15:155\u201363. https:\/\/doi.org\/10.1016\/j.jcm.2016.02.012.","journal-title":"J Chiropr Med"},{"key":"1889_CR19","doi-asserted-by":"publisher","first-page":"5523","DOI":"10.3390\/cancers14225523","volume":"14","author":"N Satvat","year":"2022","unstructured":"Satvat N, Korczynski O, M\u00fcller-Eschner M, Othman AE, Sch\u00f6ffling V, Keric N, et al. A rapid late enhancement MRI protocol improves differentiation between brain tumor recurrence and Treatment-Related contrast enhancement of brain parenchyma. Cancers. 2022;14:5523. https:\/\/doi.org\/10.3390\/cancers14225523.","journal-title":"Cancers"},{"key":"1889_CR20","doi-asserted-by":"publisher","first-page":"e52008","DOI":"10.1371\/journal.pone.0052008","volume":"7","author":"L Zach","year":"2012","unstructured":"Zach L, Guez D, Last D, Daniels D, Grober Y, Nissim O, et al. Delayed contrast extravasation MRI for depicting tumor and Non-Tumoral tissues in primary and metastatic brain tumors. PLoS ONE. 2012;7:e52008. https:\/\/doi.org\/10.1371\/journal.pone.0052008.","journal-title":"PLoS ONE"},{"key":"1889_CR21","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1093\/neuonc\/nou230","volume":"17","author":"L Zach","year":"2015","unstructured":"Zach L, Guez D, Last D, Daniels D, Grober Y, Nissim O, et al. Delayed contrast extravasation MRI: a new paradigm in neuro-oncology. Neuro-Oncol. 2015;17:457\u201365. https:\/\/doi.org\/10.1093\/neuonc\/nou230.","journal-title":"Neuro-Oncol"},{"key":"1889_CR22","doi-asserted-by":"publisher","first-page":"E117","DOI":"10.1016\/j.ijrobp.2019.06.2228","volume":"105","author":"Y Mardor","year":"2019","unstructured":"Mardor Y, Last D, Daniels D, Tylim A, Nass D, Nissim O, et al. Treatment response assessment maps (TRAMs): increased\/decreased sensitivity to tumor as a function of acquisition\/analysis parameters. Int J Radiat Oncol. 2019;105:E117. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.06.2228.","journal-title":"Int J Radiat Oncol"},{"key":"1889_CR23","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s12672-024-01266-9","volume":"15","author":"SJ M\u00fcller","year":"2024","unstructured":"M\u00fcller SJ, Khadhraoui E, Henkes H, Ernst M, Rohde V, Schatlo B, et al. Differentiation between multifocal CNS lymphoma and glioblastoma based on MRI criteria. Discov Oncol. 2024;15:397. https:\/\/doi.org\/10.1007\/s12672-024-01266-9.","journal-title":"Discov Oncol"},{"key":"1889_CR24","first-page":"2187","volume":"26","author":"N Bulakbasi","year":"2005","unstructured":"Bulakbasi N, Kocaoglu M, Farzaliyev A, Tayfun C, Ucoz T, Somuncu I. Assessment of diagnostic accuracy of perfusion MR imaging in primary and metastatic solitary malignant brain tumors. AJNR Am J Neuroradiol. 2005;26:2187\u201399.","journal-title":"AJNR Am J Neuroradiol"},{"key":"1889_CR25","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1093\/bjr\/tqae146","volume":"97","author":"C Hu","year":"2024","unstructured":"Hu C, Fang K, Du Q, Chen J, Wang L, Zhang J, et al. Diffusion-weighted MRI precisely predicts telomerase reverse transcriptase promoter mutation status in world health organization grade IV gliomas using a residual convolutional neural network. Br J Radiol. 2024;97:1806\u201315. https:\/\/doi.org\/10.1093\/bjr\/tqae146.","journal-title":"Br J Radiol"},{"key":"1889_CR26","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s00234-023-03177-y","volume":"65","author":"K Yamashita","year":"2023","unstructured":"Yamashita K, Hatae R, Kikuchi K, Kuga D, Hata N, Yamamoto H, et al. Predicting TERT promoter mutation status using 1H-MR spectroscopy and stretched-exponential model of diffusion-weighted imaging in IDH-wildtype diffuse astrocytic glioma without intense enhancement. Neuroradiology. 2023;65:1205\u201313. https:\/\/doi.org\/10.1007\/s00234-023-03177-y.","journal-title":"Neuroradiology"},{"key":"1889_CR27","doi-asserted-by":"publisher","first-page":"1533799","DOI":"10.3389\/fnins.2025.1533799","volume":"19","author":"M Knutsson","year":"2025","unstructured":"Knutsson M, Salomonsson T, Durmo F, Johansson ER, Seidemo A, L\u00e4tt J, et al. Differentiation between glioblastoma and solitary brain metastases using perfusion and amide proton transfer weighted MRI. Front Neurosci. 2025;19:1533799. https:\/\/doi.org\/10.3389\/fnins.2025.1533799.","journal-title":"Front Neurosci"},{"key":"1889_CR28","doi-asserted-by":"publisher","first-page":"554","DOI":"10.3348\/kjr.2014.15.5.554","volume":"15","author":"G-H Jahng","year":"2014","unstructured":"Jahng G-H, Li K-L, Ostergaard L, Calamante F. Perfusion magnetic resonance imaging: a comprehensive update on principles and techniques. Korean J Radiol. 2014;15:554\u201377. https:\/\/doi.org\/10.3348\/kjr.2014.15.5.554.","journal-title":"Korean J Radiol"},{"key":"1889_CR29","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro-Oncol. 2021;23:1231\u201351. https:\/\/doi.org\/10.1093\/neuonc\/noab106.","journal-title":"Neuro-Oncol"},{"key":"1889_CR30","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.3390\/diagnostics14212354","volume":"14","author":"DP Wisnu Wardhana","year":"2024","unstructured":"Wisnu Wardhana DP, Maliawan S, Mahadewa TGB, Rosyidi RM, Wiranata S. Radiomic features as artificial intelligence prognostic models in glioblastoma: A systematic review and Meta-Analysis. Diagn Basel Switz. 2024;14:2354. https:\/\/doi.org\/10.3390\/diagnostics14212354.","journal-title":"Diagn Basel Switz"},{"key":"1889_CR31","doi-asserted-by":"publisher","first-page":"461","DOI":"10.5114\/pjr.2023.132168","volume":"88","author":"A Kwiatkowska-Miernik","year":"2023","unstructured":"Kwiatkowska-Miernik A, Mruk B, Sklinda K, Zaczy\u0144ski A, Walecki J. Radiomics in the diagnosis of glioblastoma. Pol J Radiol. 2023;88:461\u20136. https:\/\/doi.org\/10.5114\/pjr.2023.132168.","journal-title":"Pol J Radiol"},{"key":"1889_CR32","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40644-024-00682-y","volume":"24","author":"H Fan","year":"2024","unstructured":"Fan H, Luo Y, Gu F, Tian B, Xiong Y, Wu G, et al. Artificial intelligence-based MRI radiomics and radiogenomics in glioma. Cancer Imaging. 2024;24:36. https:\/\/doi.org\/10.1186\/s40644-024-00682-y.","journal-title":"Cancer Imaging"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01889-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-025-01889-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01889-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:20:22Z","timestamp":1781608822000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12880-025-01889-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1889"],"URL":"https:\/\/doi.org\/10.1186\/s12880-025-01889-6","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,27]]},"assertion":[{"value":"26 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The institutional review board of the University of Magdeburg (Leipziger Str. 44, D-39104 Magdeburg, Germany, No. 103\/24) ethically approved this study, which adhered to the 2013 Helsinki Declaration. Because of the retrospective, observational nature of the study, the ethics committee waived the requirement for informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"353"}}